AC Immune (ACIU) Receivables - Other (2014 - 2026)

AC Immune (ACIU) has reported Receivables - Other for 13 consecutive years, with $1.6 billion the latest figure, recorded in Q1 2026.

• In Q1 2026, Receivables - Other rose 73939.16% year-over-year to $1.6 billion; the TTM figure through Mar 2026 stood at $1.6 billion (up 73939.16% YoY), while the FY2025 annual figure was $1.2 billion, up 93500.71% from the prior year.
• Receivables - Other climbed to $1.6 billion in Q1 2026 per ACIU's latest filing, from $1.2 billion in the prior quarter.
• Across five years, Receivables - Other topped out at $1.6 billion in Q1 2026 and bottomed at $336989.2 in Q2 2023.
• Historically, Receivables - Other has averaged $206.7 million across 5 years, with a median of $1.3 million in 2024.
• Annual changes were most pronounced in 2022 — Receivables - Other tumbled 99.91% — and 2025, when it jumped 96996.1%.
• AC Immune's Receivables - Other stood at $406904.6 in 2022, then soared by 72.33% to $701214.5 in 2023, then surged by 79.72% to $1.3 million in 2024, then surged by 96996.1% to $1.2 billion in 2025, then jumped by 33.79% to $1.6 billion in 2026.
• Business Quant data shows ACIU's Receivables - Other at $1.6 billion in Q1 2026, $1.2 billion in Q4 2025, and $2.0 million in Q3 2025.